Related Experiment Video
Updated: Jun 26, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Indoxyl Sulfate Aggravates Podocyte Damage through the TGF-β1/Smad/ROS Signalling Pathway
Miao Jia1, Lihua Lin1, Kang Xun1
1Department of Nephrology, The People's Hospital of Suzhou New District, Suzhou, China.
Introduction:
Hyperglycaemia induces the production of a large quantity of reactive oxygen species (ROS) and activates the transforming growth factor β1 (TGF-β1)/Smad signalling pathway, which is the main initiating factor in the formation of diabetic nephropathy. Indoxyl sulphate (IS) is a protein-binding gut-derived uraemic toxin that localizes to podocytes, induces oxidative stress, and inflames podocytes. The involvement of podocyte damage in diabetic nephropathy through the TGF-β1 signalling pathway is still unclear.
Methods:
In this study, we cultured differentiated rat podocytes in vitro and measured the expression levels of nephrin, synaptopodin, CD2AP, SRGAP2a, and α-SMA by quantitative real-time PCR (qRT-PCR) and Western blotting after siRNA-mediated TGF-β1 silencing, TGF-β1 overexpression, and the presence of the ROS inhibitor acetylcysteine. We detected the expression levels of nephrin, synaptopodin, CD2AP, SRGAP2a, small mother against decapentaplegic (Smad)2/3, phosphorylated-Smad2/3 (p-Smad2/3), Smad7, NADPH oxidase 4 (NOX4), and ROS levels under high glucose (HG) and IS conditions.
Results:
The results indicated that nephrin, synaptopodin, CD2AP, and SRGAP2a expressions were significantly upregulated, and α-SMA expression was significantly downregulated in the presence of HG under siRNA-mediated TGF-β1 silencing or after the addition of acetylcysteine. However, in the presence of HG, the expressions of nephrin, synaptopodin, CD2AP, and SRGAP2a were significantly downregulated, and the expression of α-SMA was significantly upregulated with the overexpression of TGF-β1. IS supplementation under HG conditions further significantly reduced the expressions of nephrin, synaptopodin, CD2AP, and SRGAP2a; altered the expressions of Smad2/3, p-Smad2/3, Smad7, and NOX4; and increased ROS production in podocytes.
Conclusion:
This study suggests that IS may modulate the expression of nephrin, synaptopodin, CD2AP, and SRGAP2a by regulating the ROS and TGF-β1/Smad signalling pathways, providing new theoretical support for the treatment of diabetic nephropathy.
Insights
Indoxyl sulphate (IS) worsens diabetic nephropathy by increasing oxidative stress and altering TGF-β1/Smad signaling in podocytes. This study reveals IS impacts key proteins, offering new therapeutic targets for diabetic kidney disease.
Area of Science:
- Nephrology
- Diabetology
- Molecular Biology
Background:
- Diabetic nephropathy is driven by hyperglycemia-induced reactive oxygen species (ROS) and transforming growth factor β1 (TGF-β1)/Smad signaling.
- Indoxyl sulphate (IS), a gut-derived uremic toxin, exacerbates podocyte injury via oxidative stress and inflammation.
- The precise role of TGF-β1 signaling in IS-induced podocyte damage in diabetic nephropathy remains incompletely understood.
Purpose of the Study:
- To investigate the impact of Indoxyl Sulphate (IS) on podocyte injury markers.
- To elucidate the involvement of reactive oxygen species (ROS) and the transforming growth factor β1 (TGF-β1)/Smad signaling pathway in IS-mediated podocyte damage.
- To explore potential therapeutic strategies for diabetic nephropathy by understanding IS effects.
Main Methods:
- Cultured differentiated rat podocytes in vitro.
- Utilized quantitative real-time PCR (qRT-PCR) and Western blotting to measure protein and gene expression levels.
- Manipulated TGF-β1 levels (silencing and overexpression), used a ROS inhibitor (acetylcysteine), and exposed cells to high glucose (HG) and IS.
Main Results:
- High glucose (HG) conditions, when combined with TGF-β1 silencing or ROS inhibition, upregulated protective podocyte markers (nephrin, synaptopodin, CD2AP, SRGAP2a) and downregulated α-SMA.
- Conversely, HG with TGF-β1 overexpression downregulated protective markers and upregulated α-SMA.
- IS supplementation under HG conditions significantly reduced protective markers, altered Smad signaling components (Smad2/3, p-Smad2/3, Smad7), affected NOX4 expression, and increased ROS production.
Conclusions:
- Indoxyl sulphate (IS) significantly contributes to podocyte damage in diabetic nephropathy.
- IS modulates the expression of key podocyte proteins by regulating ROS production and the TGF-β1/Smad signaling pathway.
- These findings offer novel theoretical support for developing treatments targeting IS, ROS, and TGF-β1/Smad pathways for diabetic nephropathy.
More Related Videos
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
14:18Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
Related Concept Videos
TGF - β Signaling Pathway
The JAK-STAT Signaling Pathway
Desensitization and Tachyphylaxis